BN

Beteiligungsgesellschaft Neue Länder

Description

Beteiligungsgesellschaft Neue Länder.

Investor Profile

Beteiligungsgesellschaft Neue Länder has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in Germany.
  • Strong thematic focus on Biopharma, Biotechnology, Therapeutics.

Stage Focus

  • Series B (100%)

Country Focus

  • Germany (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Beteiligungsgesellschaft Neue Länder frequently co-invest with?

Co-Investments: 1
3i Group
Europe, England, United Kingdom, London
Co-Investments: 1
Bayern Kapital
Europe, Bayern, Germany, Landshut
Co-Investments: 1
Deutsche Venture Capital
Europe, Bayern, Germany, München
Co-Investments: 1

What are some of recent deals done by Beteiligungsgesellschaft Neue Länder?

4SC

Planegg, Bayern, Germany

4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases.

BiopharmaBiotechnologyTherapeutics
Series BDec 12, 2000
Amount Raised: $15,030,853

Find More Investors Like Beteiligungsgesellschaft Neue Länder

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Beteiligungsgesellschaft Neue Länder | Pipeseed